Oncology Institute (TOIIW) Operating Expenses (2020 - 2026)

Oncology Institute has reported Operating Expenses for 7 years, with the latest figure at $154.0 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 34.67% year-over-year to $154.0 million; the trailing twelve-month figure through Mar 2026 stood at $578.4 million (up 27.07% YoY), and the FY2025 full-year result was $538.8 million, up 18.8% from the prior year.
• Operating Expenses for Q1 2026 stood at $154.0 million, up from $148.9 million in the prior quarter.
• The five-year high for Operating Expenses was $154.0 million in Q1 2026, with the low at $73.6 million in Q1 2022.
• Historically, Operating Expenses has averaged $110.7 million across 5 years, with a median of $112.2 million in 2024.
• Annual changes were most pronounced in 2022 — Operating Expenses soared 56.29% — and 2025, when it climbed 1.49%.
• Oncology Institute's Operating Expenses stood at $96.5 million in 2022, then rose by 4.74% to $101.1 million in 2023, then grew by 11.0% to $112.2 million in 2024, then surged by 32.68% to $148.9 million in 2025, then climbed by 3.42% to $154.0 million in 2026.
• The last three Operating Expenses figures came in at $154.0 million (Q1 2026), $148.9 million (Q4 2025), and $144.6 million (Q3 2025), per Business Quant data.